{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:03:39Z","timestamp":1790935419319,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T00:00:00Z","timestamp":1455321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Experimental Cancer Medicine Centre Network"},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00280-016-2975-0","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T14:47:02Z","timestamp":1455374822000},"page":"685-692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens"],"prefix":"10.1007","volume":"77","author":[{"given":"Gareth J.","family":"Veal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Errington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairam","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Pritchard-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanzina","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,13]]},"reference":[{"key":"2975_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003088-198814040-00001","volume":"14","author":"JB Besunder","year":"1988","unstructured":"Besunder JB, Reed MD, Blumer JL (1988) Principles of drug biodisposition in the neonate (part I). Clin Pharmacokinet 14:189\u2013216","journal-title":"Clin Pharmacokinet"},{"key":"2975_CR2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology\u2014drug disposition, action and therapy in infants and children. New Engl J Med 349:1157\u20131167","journal-title":"New Engl J Med"},{"key":"2975_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/pbc.22343","volume":"54","author":"PC Adamson","year":"2010","unstructured":"Adamson PC (2010) It\u2019s not easy being small. Pediatr Blood Cancer 54:341\u2013343","journal-title":"Pediatr Blood Cancer"},{"key":"2975_CR4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003088-200645110-00003","volume":"45","author":"IH Bartelink","year":"2006","unstructured":"Bartelink IH, Rademaker CM, Schobben AF, van den Anker JN (2006) Guidelines on paediatric dosing on the basis of development physiology and pharmacokinetic considerations. Clin Pharmacokinet 45:1077\u20131097","journal-title":"Clin Pharmacokinet"},{"key":"2975_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ctrv.2011.03.005","volume":"38","author":"H Berg van den","year":"2012","unstructured":"van den Berg H, van den Anker JN, Beijnen JH (2012) Cytostatic drugs in infants: a review on pharmacokinetic data in infants. Cancer Treat Rev 38:3\u201326","journal-title":"Cancer Treat Rev"},{"key":"2975_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00441807","volume":"148","author":"AJ Heijden Van der","year":"1988","unstructured":"Van der Heijden AJ, Grose WFA, Ambagtsheer JJ, Provoost AP, Wolff ED, Sauer PJJ (1988) Glomerular filtration rate in the preterm infant: the relation to gestational and postnatal age. Eur J Paediatr 148:24\u201328","journal-title":"Eur J Paediatr"},{"key":"2975_CR7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2165\/00003088-200241120-00003","volume":"41","author":"J Alcorn","year":"2002","unstructured":"Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 41:959\u2013998","journal-title":"Clin Pharmacokinet"},{"key":"2975_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00280-008-0787-6","volume":"63","author":"SV Picton","year":"2009","unstructured":"Picton SV, Keeble J, Holden V, Errington J, Boddy AV, Veal GJ (2009) Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma. Cancer Chemother Pharmacol 63:749\u2013752","journal-title":"Cancer Chemother Pharmacol"},{"key":"2975_CR9","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ejca.2015.07.011","volume":"51","author":"GJ Veal","year":"2015","unstructured":"Veal GJ, Errington J, Hayden J, Hobin D, Murphy D, Dommett RM et al (2015) Carboplatin therapeutic monitoring in preterm and full-term neonates. Eur J Cancer 51:2022\u20132030","journal-title":"Eur J Cancer"},{"key":"2975_CR10","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00467-010-1533-y","volume":"25","author":"DP Boer","year":"2010","unstructured":"Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM (2010) Reference values for serum creatinine in children younger than 1\u00a0year of age. Pediatr Nephrol 25:2107\u20132113","journal-title":"Pediatr Nephrol"},{"key":"2975_CR11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinchem\/43.1.228","volume":"43","author":"P Rosenthal","year":"1997","unstructured":"Rosenthal P (1997) Assessing liver function and hyperbilirubinemia in the newborn. Clin Chem 43:228\u2013234","journal-title":"Clin Chem"},{"key":"2975_CR12","first-page":"2205","volume":"7","author":"GJ Veal","year":"2001","unstructured":"Veal GJ, Dias C, Price L, Parry A, Errington J, Hale J et al (2001) Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy. Clin Cancer Res 7:2205\u20132212","journal-title":"Clin Cancer Res"},{"key":"2975_CR13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.bjc.6603607","volume":"96","author":"GJ Veal","year":"2007","unstructured":"Veal GJ, Errington J, Tilby MJ, Pearson AD, Foot AB, McDowell H et al (2007) Adaptive dosing and platinum-DNA adduct formation in children receiving high dose carboplatin for the treatment of solid tumours. Br J Cancer 96:725\u2013731","journal-title":"Br J Cancer"},{"key":"2975_CR14","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.ejca.2010.03.002","volume":"46","author":"T Israels","year":"2010","unstructured":"Israels T, Damen CWN, Cole M, van Geloven N, Boddy AV, Caron HN et al (2010) Malnourished Malawian patients presenting with large Wilms tumours have a decreased vincristine clearance rate. Eur J Cancer 46:1841\u20131847","journal-title":"Eur J Cancer"},{"key":"2975_CR15","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00280-009-1111-9","volume":"65","author":"GJ Veal","year":"2010","unstructured":"Veal GJ, Cole M, Errington J, Pearson AD, Gerrard M, Whyman G et al (2010) Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients. Cancer Chemother Pharmacol 65:1057\u20131066","journal-title":"Cancer Chemother Pharmacol"},{"key":"2975_CR16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/0959-8049(95)00382-S","volume":"31A","author":"B Peng","year":"1995","unstructured":"Peng B, Boddy AV, Cole M, Pearson AD, Chatelut E, Rubie H et al (1995) Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients. Eur J Cancer 31A:1804\u20131810","journal-title":"Eur J Cancer"},{"key":"2975_CR17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0959-8049(97)00341-9","volume":"33","author":"B Peng","year":"1997","unstructured":"Peng B, English MW, Boddy AV, Price L, Wyllie R, Pearson AD et al (1997) Cisplatin pharmacokinetics in children with cancer. Eur J Cancer 33:1823\u20131828","journal-title":"Eur J Cancer"},{"key":"2975_CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpt.176","volume":"98","author":"KL Brouwer","year":"2015","unstructured":"Brouwer KL, Aleksunes LM, Brandys B, Giacoia GP, Knipp G, Lukacova V et al (2015) Human ontogeny of drug transporters: review and recommendations of the Pediatric Transporter Working Group. Clin Pharmacol Ther 98:266\u2013287","journal-title":"Clin Pharmacol Ther"},{"key":"2975_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.siny.2012.03.002","volume":"17","author":"GJ Veal","year":"2012","unstructured":"Veal GJ, Boddy AV (2012) Chemotherapy in newborns and preterm babies. Semin Fetal Neonatal Med 17:243\u2013248","journal-title":"Semin Fetal Neonatal Med"},{"key":"2975_CR20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2125.2009.03591.x","volume":"70","author":"M Cella","year":"2010","unstructured":"Cella M, Knibbe C, Danhof M, Della Pasqua O (2010) What is the right dose for children? Br J Clin Pharmacol 70:597\u2013603","journal-title":"Br J Clin Pharmacol"},{"key":"2975_CR21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0091270006286793","volume":"46","author":"J Goodisman","year":"2006","unstructured":"Goodisman J, Souid AK (2006) Constancy in integrated cisplatin plasma concentrations among pediatric patients. J Clin Pharmacol 46:443\u2013448","journal-title":"J Clin Pharmacol"},{"key":"2975_CR22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3476(94)70027-3","volume":"125","author":"WR Crom","year":"1994","unstructured":"Crom WR, de Graaf SS, Synold T, Uges DR, Bloemhof H, Rivera G et al (1994) Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia. J Pediatr 125:642\u2013649","journal-title":"J Pediatr"},{"key":"2975_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.2010.29.5196","volume":"29","author":"H Rubie","year":"2011","unstructured":"Rubie H, De Bernardi B, Gerrard M, Canete A, Ladenstein R, Couturier J et al (2011) Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol 29:449\u2013455","journal-title":"J Clin Oncol"},{"key":"2975_CR24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1442-200X.2003.01675.x","volume":"45","author":"Y Kato","year":"2003","unstructured":"Kato Y, Nishimura S-I, Sakura N, Ueda K (2003) Pharmacokinetics of etoposide with intravenous drug administration in children and adolescents. Pediatr Int 45:74\u201379","journal-title":"Pediatr Int"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-2975-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-2975-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-2975-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T10:53:00Z","timestamp":1600167180000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-2975-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,13]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-2975-0","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,13]]}}}